| Activation of stimulator of IFN genes (STING) causes proteinuria and contributes to glomerular diseases A Mitrofanova, A Fontanella, M Tolerico, S Mallela, JM David, Y Zuo, ... Journal of the American Society of Nephrology 33 (12), 2153-2173, 2022 | 31 | 2022 |
| Treatment outcomes for patients with Ga68-PSMA-PET prostate cancer (PC) with or without conventional imaging correlates. W Issa, M Aliru, D Gunenc, S Zhang, Q Zhou, Q Qin, J Wang, W Arafat, ... Journal of Clinical Oncology 42 (16_suppl), 5078-5078, 2024 | | 2024 |
| Impact of β-adrenergic blockade on efficacy of immunotherapy in patients with metastatic clear cell renal cell carcinoma. K Semaan, M Eid, E Saad, W Issa, RM Saliby, M Paul, C Zhong, ... Journal of Clinical Oncology 42 (16_suppl), e16529-e16529, 2024 | | 2024 |
| Predictive risk model for radiation-induced pneumonitis in patients diagnosed with advanced esophageal cancer receiving radiation therapy alone or in combination with … W Qu, X Wen, R Duan, W Issa, X Ren, Z Ren, L Zhang, X Ding | | 2024 |
| Association of radiographic and pathologic outcomes in patients (pts) with advanced renal cell carcinoma (RCC) with and without thrombus receiving preoperative immune … W Issa, D Gunenc, S Zhang, Q Zhou, T Gerald, I Tachibana, ... Journal of Clinical Oncology 42 (4_suppl), 415-415, 2024 | | 2024 |
| Lipid Parameters and Proprotein Convertase Subtilisin/Kexin Type 9 in Healthy Lebanese Adults MH Gannagé-Yared, E Naous, A Al Achkar, W Issa, G Sleilaty, ... Metabolites 12 (8), 690, 2022 | | 2022 |
| Pathological Response and Outcomes of Patients with Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy after Immunotherapy Regimens D Gunenc, T Gerald, W Issa, G Carpinito, J Brugarolas, H Hammers, ... Age (Mean) 59, 62.53, 0 | | |
